Page 54 - Read Online

Author Instructions

Perspective A Perspective provides None required. None / 3,000 words
personal points of view required. max excluding,
on the state-of-the-art of a references,
specific area of knowledge igures and tables.
and its future prospects. Reference: Max of
Links to areas of intense 70
current research focus Table/Figure: Max
can also be made. The of 1
emphasis should be on a
personal assessment rather
than a comprehensive,
critical review. However,
comments should be put
into the context of existing
literature. Perspectives
are usually invited by the
Editors.
Research Research Highlights None required. None / "1,200 words
Highlight discuss the main advances required. max excluding,
made by the paper as well references, figures
as putting the finds of and tables.
the study into the proper Table/Figure: Max
context of the field. of 1"

Short Short Communications Structured 3-8 keywords The main content should include /
Communications are articles that present abstract four sections: Introduction,
groundbreaking including Methods, Results and
preliminary results or Aim, Methods, Discussion.
significant findings that are Results and
part of a larger study over Conclusion. No
multiple years. They can more than 250
also include cutting-edge words
methods or experiments,
and the development
of new technology or
materials. The structure is
similar to an article.
Case Report A Case Report provides Unstructured 3-8 keywords / /
a detailed description of abstract. No
an individual patient or a more than 150
small number of cases that words.
illustrate rare conditions,
unusual presentations,
innovative diagnostic
approaches, or noteworthy
treatment outcomes.
Authors should adhere to
the CARE checklist.

Conference Conference reports are Unstructured 3-8 keywords / /
Report records of the events of abstract; max
a conference, seminar, word limit: 250
or meeting. They should
provide a comprehensive
overview of a meeting or
session, along with relevant
background information
for the reader.

Rare Disease and Orphan Drugs Journal VII